Acceleron Pharma
(XLRN)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2015 | 12-2014 | 12-2013 | 12-2012 | 12-2011 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -63,894 | -51,259 | -21,898 | -32,582 | 36,266 |
| Depreciation Amortization | 1,176 | 1,154 | 1,101 | 1,428 | 3,375 |
| Accounts receivable | -261 | 249 | -844 | -1,124 | 1,830 |
| Accounts payable and accrued liabilities | 151 | -161 | -53 | -1,272 | 334 |
| Other Working Capital | 3,276 | -2,345 | -28,459 | -11,529 | -32,764 |
| Other Operating Activity | 15,341 | -858 | 30,503 | 6,195 | 15 |
| Operating Cash Flow | $-44,211 | $-53,220 | $-19,650 | $-38,884 | $9,056 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 26,685 | N/A | N/A | N/A | N/A |
| PPE Investments | -959 | -514 | -307 | -441 | -27 |
| Purchase Of Investment | -134,697 | 0 | N/A | N/A | N/A |
| Investing Cash Flow | $-108,971 | $-514 | $-307 | $-441 | $-27 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | 19,935 | N/A |
| Debt Repayment | N/A | -16,331 | -3,669 | -6,191 | -9,476 |
| Common Stock Issued | 4,505 | 133,362 | 97,478 | 155 | 190 |
| Other Financing Activity | 0 | 0 | -300 | 0 | 30,378 |
| Financing Cash Flow | $4,505 | $117,031 | $93,509 | $13,899 | $21,092 |
| Beginning Cash Position | 176,460 | 113,163 | 39,611 | 65,037 | 34,916 |
| End Cash Position | 27,783 | 176,460 | 113,163 | 39,611 | 65,037 |
| Net Cash Flow | $-148,677 | $63,297 | $73,552 | $-25,426 | $30,121 |
| Free Cash Flow | |||||
| Operating Cash Flow | -44,211 | -53,220 | -19,650 | -38,884 | 9,056 |
| Capital Expenditure | -959 | -514 | -307 | -441 | -27 |
| Free Cash Flow | -45,170 | -53,734 | -19,957 | -39,325 | 9,029 |